The Erasmus Medical Center in Rotterdam (serving 3 million people) is implementing the use of Affymetrix microarray technology for every area of research. The goal is to take genetic and genomic research that is consistent and reproducible–as required for clinical trials–and translate it into clinical tools to improve patient care.